molecules-logo

Journal Browser

Journal Browser

Anticancer Bioactivities of Minor Flavonoids

A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Natural Products Chemistry".

Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 3587

Special Issue Editor

Special Issue Information

Dear Colleagues,

Over the recent decades, a huge number of studies have focused on anticancer activities of plant-derived flavonoids, including structurally different flavanols (or catechins), flavones, flavonols, flavanones, isoflavones and anthocyanidins. These works have revealed important mechanisms how flavonoids can interact with diverse molecular targets and intervene in cellular signaling pathways, leading to prevention or retardation of cancer growth. However, it is well known that plants biosynthesize also other types of flavonoids, known as the so-called minor flavonoids, comprising aurones, chalcones, dihydrochalcones and dihydroflavonols (or flavononols). The current knowledge about bioactivities of minor flavonoids is still much more scarce today, although some studies clearly point to the important anticancer potential of these natural agents. Therefore, this special issue is devoted to different chemopreventive and anticancer effects of minor flavonoids, including their anti/pro-oxidant, antiinflammatory, antiproliferative, proapoptotic, antimigratory, antiinvasive, antiangiogenic and antimetastatic properties, encouraging researchers to explore also the minor types of plant-derived polyphenols. It is highly expected that these studies could result in identification of novel molecular leads for new anticancer agents, expanding our current arsenal in the fight against malignant disorders. Considering the ever-increasing incidence of new cancer cases all over the world in the 21st century, such efforts can be highly valuable from a clinical point of view. Besides review articles, original research papers are very welcomed to be submitted to this special issue to encourage experimental investigation into the field of plant-derived anticancer agents and provide new knowledge about natural sources and possible anticancer effects of little-explored minor phenolics like aurones aureusidin, hispidol, leptosidin and sulfuretin; dihydrochalcones aspalathin, nothofagin and phloretin; flavononols taxifolin, ampelopsin and aromadendrin; and other compounds from these minor but not less important flavonoids` subclasses. Papers about possible co-effects of these natural agents (as well as their semisynthetic derivatives) with conventional cancer treatment modalities are also anticipated in this special issue.

Dr. Katrin Sak
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • plant polyphenols
  • minor flavonoids
  • anticancer activities
  • apoptosis
  • metastasis
  • angiogenesis
  • molecular mechanisms

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

15 pages, 1701 KiB  
Review
Phloretin, as a Potent Anticancer Compound: From Chemistry to Cellular Interactions
by Hardeep Singh Tuli, Prangya Rath, Abhishek Chauhan, Seema Ramniwas, Kanupriya Vashishth, Mehmet Varol, Vivek Sheel Jaswal, Shafiul Haque and Katrin Sak
Molecules 2022, 27(24), 8819; https://doi.org/10.3390/molecules27248819 - 12 Dec 2022
Cited by 11 | Viewed by 2297
Abstract
Phloretin is a natural dihydrochalcone found in many fruits and vegetables, especially in apple tree leaves and the Manchurian apricots, exhibiting several therapeutic properties, such as antioxidant, antidiabetic, anti-inflammatory, and antitumor activities. In this review article, the diverse aspects of the anticancer potential [...] Read more.
Phloretin is a natural dihydrochalcone found in many fruits and vegetables, especially in apple tree leaves and the Manchurian apricots, exhibiting several therapeutic properties, such as antioxidant, antidiabetic, anti-inflammatory, and antitumor activities. In this review article, the diverse aspects of the anticancer potential of phloretin are addressed, presenting its antiproliferative, proapoptotic, antimetastatic, and antiangiogenic activities in many different preclinical cancer models. The fact that phloretin is a planar lipophilic polyphenol and, thus, a membrane-disrupting Pan-Assay Interference compound (PAIN) compromises the validity of the cell-based anticancer activities. Phloretin significantly reduces membrane dipole potential and, therefore, is expected to be able to activate a number of cellular signaling pathways in a non-specific way. In this way, the effects of this minor flavonoid on Bax and Bcl-2 proteins, caspases and MMPs, cytokines, and inflammatory enzymes are all analyzed in the current review. Moreover, besides the anticancer activities exerted by phloretin alone, its co-effects with conventional anticancer drugs are also under discussion. Therefore, this review presents a thorough overview of the preclinical anticancer potential of phloretin, allowing one to take the next steps in the development of novel drug candidates and move on to clinical trials. Full article
(This article belongs to the Special Issue Anticancer Bioactivities of Minor Flavonoids)
Show Figures

Figure 1

Back to TopTop